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ABSTRACT
The aim of this study was to evaluate the accuracy of Tc-99m polyclonal human immunoglobulin (HIG)
scintigraphy for the diagnosis of brucellosis, and to compare its effectiveness in the diagnosis of
osteoarticular involvement in comparison with bone scanning. Of 30 patients with brucellosis, Tc-99m
HIG detected osteoarticular involvement in 18 (60%) patients, in whom the sacroiliac joints were
affected most commonly (n = 13; 72.2%), with statistically predominant bilateral involvement (p < 0.05).
By bone scanning, the rate of osteoarticular involvement was 70% (21 of 30 patients), and the joints
affected most commonly were sacroiliac (15 of 21 patients; 71.4%). Although bilateral involvement was
observed mostly by bone scanning, there was no signiﬁcant difference between the rate of bilateral and
unilateral involvement. The anatomical distribution of osteoarticular complications, as detected by
Tc-99m HIG and bone scintigraphy, did not differ signiﬁcantly. With Tc-99m HIG, orchitis was detected
in two patients and paravertebral abscess in one patient. Since bone scanning did not detect these soft
tissue complications, Tc-99m HIG scintigraphy might be useful for the detection of both osteoarticular
and soft tissue complications resulting from brucellosis.
Keywords Brucellosis, bone scintigraphy, diagnosis, HIG scintigraphy, osteoarthricular involvement, soft tissue
involvement.
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INTRODUCTION
Brucellosis is an important public health problem
throughout the world, particularly in the Medi-
terranean region, the Arabian Peninsula, the
Indian subcontinent, Mexico, and parts of Central
and South America [1–4]. Brucella spp. are pri-
marily animal pathogens, and although brucello-
sis has been an occupational disease in developed
countries, it is a common health problem in other
countries as a result of the consumption of
non-pasteurised milk or milk products from
infected animals. The disease can occur at any
age, but affects mostly adolescents and young
adults [4–6]. Brucellosis is a systemic infection in
which any organ or system of the body can be
involved. Organ involvement is often referred to
as localised disease, and can be either a compli-
cation of acute brucellosis, or may be the only
manifestation of chronic brucellosis. Osteoarticu-
lar involvement is the most common complication
of brucellosis, and includes spondylitis, sacroili-
itis, arthritis, tenosynovitis and osteomyelitis
[1,2,7]. Clinical manifestations of brucellosis are
varied, and include rheumatic symptoms in
20–85% of patients [8].
Radionuclide bone scan has been shown to be a
sensitive method for detecting bone lesions
resulting from brucellosis throughout the body
[9–11]. Since bone scintigraphy is a highly sensi-
tive but non-speciﬁc method, increased radiotrac-
er uptake by joints, especially the sacroiliac joints
and vertebral column, does not always indicate
articular involvement of brucellosis. Therefore,
increased radiotracer uptake of a certain joint
could be evaluated in terms of infectious or
inﬂammatory activity by using radionuclide
agents to diagnose inﬂammation or infection.
Moreover, use of these agents has additional
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beneﬁts that are impossible to obtain with bone
scans alone, such as allowing an evaluation of the
soft tissue involvement of brucellosis. Tc-99m
polyclonal human immunoglobulin (HIG) scin-
tigraphy is one of the methods that can be used to
image non-pyogenic infection and inﬂammation
in different tissues, such as soft tissue, bone and
joints, and in ophthalmopathy. Although there
are many reports of the detection of brucellosis
osteoarticular involvement by bone scintigraphy
[9–11], no previous studies in the English scien-
tiﬁc literature have investigated the use of HIG
scintigraphy. Therefore, the aim of the present
study was to evaluate the diagnostic accuracy of
Tc-99m HIG scintigraphy for the detection of
localised disease, and to compare its diagnostic
efﬁcacy for osteoarticular involvement with that
of bone scans.
MATERIALS AND METHODS
Patients
This was a prospective study of 30 patients with brucellosis
who were admitted to the Infectious Diseases and Clinical
Microbiology Department between June 2001 and January
2004. Complete medical histories and physical examinations
were performed. Laboratory assessments included complete
blood count (CBC), erythrocyte sedimentation rate (ESR),
C-reactive protein (CRP), blood chemistry, including levels of
alanine aminotransferase (ALT) and aspartate aminotransf-
erase (AST), cultures from blood and bone marrow, and
Wright’s test [12]. Brucellosis was diagnosed on the basis of
one of the following criteria:
1 Isolation of Brucella spp. in blood, other body ﬂuids or tissue
samples (Bactec 9120; Becton Dickinson, Sparks, MD, USA);
2 A compatible clinical picture, such as arthralgia, fever,
sweating, chills, headache and malaise, supported by the
detection of speciﬁc antibodies at signiﬁcant titres and ⁄ or at
least a four-fold rise in antibody titre in serum specimens
taken over 2–3 weeks. Signiﬁcant titres were deﬁned as
‡1 ⁄ 160 in the standard tube agglutination test (Wright’s test)
[12]. Antigens prepared from Brucella abortus strain S99
(Pendik Veterinary Research Laboratory, Istanbul, Turkey)
were used. Cases were classiﬁed as acute (symptom
duration <8 weeks) or sub-acute (8–52 weeks) [1,2,7].
For all patients, Tc-99m HIG scintigraphy and bone scan
were performed ‡2 days apart following informed consent.
Whole-body images were obtained (12 cm ⁄min) in the anterior
and posterior projections within 2–3 h of the intravenous
injection of 740 MBq Tc-99mmethylene diphosphonate (MDP).
Both anterior and posterior images of the pelvis and posterior
images of dorsal spine were also acquired. A commercially
available Tc-99m HIG kit (Malinkrodt, Petten, Holland) was
used. In total, 740 Mbq Tc-99m pertechnetate was added
aseptically to the vial and, 30 min after incubation, 370 MBq
Tc-99m HIG was injected via the antecubital vein. The whole
body images, in addition to anterior and posterior planar
images of the pelvis, were acquired 4 h after injection. A
double-headed gamma camera connected to a computer and
equipped with a low-energy and high-resolution collimator
was used (Siemens e-cam; Siemens Medical Solutions, Hoff-
man Estates, IL, USA) for image collection.
Bone scans and Tc-99m HIG scintigraphy were evaluated
visually by an experienced nuclear medicine physician who
was unaware of the clinical information. Bone scans were
interpreted according to standard clinical practice, using
location, intensity and conﬁguration of increased tracer
activity. Bone scintigraphy was interpreted as positive for
osteoarticular involvement of brucellosis if the radiotracer
activity in the sacroiliac joints, vertebral column or any other
joint was greater than normal bony uptake. Results were
considered negative if there was no signiﬁcant radiotracer
uptake in the sacroiliac joints or other areas. Any Tc-99m HIG
images with increased accumulation of radioactivity in the
bony structure, especially in the sacroiliac joint and vertebral
column or other joints, was considered abnormal. Any
increased HIG activity in the sacroiliac joints, if present, was
compared with the uptake of MDP for conﬁrmation of active
inﬂammation. Clinically, sacroiliitis was recorded through
either the Fabere test (ﬂexion-abduction-external rotation) or
by direct pelvic compression. In addition to bone uptake of
Tc-99m HIG, soft tissue uptake of this radiopharmaceutical,
except normal distribution of HIG, was interpreted with
respect to diagnosis of the soft tissue complications of
brucellosis. Diagnosis of soft tissue complications of brucel-
losis was conﬁrmed by either ultrasonography (US) or
magnetic resonance imaging (MRI).
Several approaches were used for treatment of adult
patients: (i) tetracycline (500 mg orally ⁄ 6 h) or doxycycline
(100 mg orally ⁄ 12 h) for 45 days plus streptomycin (1 g
intramuscularly ⁄day) for the ﬁrst 21 days; or (ii) doxycycline
(100 mg orally ⁄ 12 h) plus rifampicin (15 mg orally ⁄kg) for
45 days. In a patient with spondylitis and paravertebral
abscess, doxycycline (100 mg orally ⁄ 12 h) plus streptomycin
(1 g intramuscularly ⁄day) therapy was started. With the
exception of this patient, who later chose to continue therapy
in a clinic closer to his home, all patients with spondylitis and
paravertebral abscess were followed for ‡6 months from the
start of therapy. Relapse was deﬁned as initial improvement,
but with reappearance of symptoms and signs during the
treatment period or £2 months after discontinuation of treat-
ment. Cure was deﬁned as no recurrence of symptoms and
signs during a 6-month follow-up period. Therapy was not
interrupted for any of the patients, and no cases of relapse or
therapeutic failure were seen.
Statistics
Statistical analysis was carried out using SAS v.8 software
(SAS Institute, Cary, NC, USA). Statistical differences between
groups were determined by v2 and student-t-tests as appro-
priate. A p value < 0.05 was considered to be statistically
signiﬁcant.
RESULTS
Thirty patients (13 (43.3%) females) with a mean
age of 33.7 ± 15.8 years (range 15–73 years) with
brucellosis were analysed. The time between onset
of symptoms and diagnosis was 7.6 ± 5.4 weeks.
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Fourteen cases were classiﬁed as acute, and 16 as
sub-acute brucellosis. A potential source of infec-
tion was identiﬁed for 25 (83.3%) patients.
Nineteen (63.3%) patients had consumed unpas-
teurised dairy products, especially fresh cheese,
while the remaining six (20%) patients had
either direct contact with animals, or worked
with animal products originating from sheep or
goats.
With Tc-99m HIG scintigraphy, the osteoartic-
ular system was affected most commonly (18
patients; 60%), while the joints most affected
were sacroiliac (13 (72.2%) of 18 patients) with
statistically predominant (p < 0.05) bilateral
involvement. The second most affected joints in
patients with osteoarticular involvement were
peripheral. Spondylitis and paravertebral abscess
were found in one patient, conﬁrmed by MRI
scans, whereas orchitis was found in two patients
with Tc-99m HIG scintigraphy, and was con-
ﬁrmed by US.
Using bone scans, the frequency of osteoartic-
ular involvement was 70% (21 of 30 patients) and
the joints most affected were sacroiliac (15 (71.4%)
of 21 patients). Although bilateral involvement
was observed, there was no signiﬁcant difference
between the rate of bilateral and unilateral
involvement. The second most affected joints in
patients with osteoarticular involvement were
peripheral. Spondylitis was found in one patient.
The anatomical distribution of osteoarticular
complications of brucellosis detected with Tc-99m
HIG and bone scintigraphy were compared, and
no signiﬁcant differences were found (Table 1).
Symptoms were mainly fever (76.7%), sweating
(73.3%), and arthralgia ⁄ arthritis (63.3%), whereas
the signs were mainly fever (76.7%) and spleno-
megaly (60%) (Table 2). In addition, patients
with orchitis had a painful scrotal swelling, while
the patient with paravertebral abscess had intense
back pain.
Brucella spp. was isolated from 16 patients; 13
isolates were from blood and threewere from bone
marrow (Table 3). The duration of symptoms was
7 ± 6.2 weeks in culture-positive and 8.2 ±
4.4 weeks in culture-negative patients (p > 0.05).
Treatment regimens comprised doxycycline plus
rifampicin for 11 patients; doxycycline plus strep-
tomycin for 18 patients; and tetracycline plus
streptomycin for one patient. All patients were
cured and there were no signiﬁcant differences
between the various therapeutic regimens.
DISCUSSION
Brucellosis is endemic in Turkey. The main
sources of Brucella are infected animals or their
products, and routes of transmission to man
include direct contact with infected animals and
their secretions through skin cuts and abrasions,
inhalation of infected aerosols, inoculation into
the conjunctival sac of the eyes, or ingestion of
unpasteurised dairy products [1,7]. The hospital
Table 1. Anatomical distribution of osteoarticular compli-
cations of brucellosis detected with Tc-99m polyclonal
human immunoglobulin (HIG) and bone scintigraphy in
30 patients
HIG Bone scanning
p valueNumber (%) of patients
Sacroiliitis 13 (43.3%) 15 (50%) >0.05 a
symmetrical 10 (33.3%) 10 (33.3%)
asymmetrical 3 (10%) 5 (16.7%)
Peripheral arthritis 6 (20%) 9 (30%) >0.05 a
Spondylytis 1 (3.3%) 1 (3.3%)
Total number of patients
with osteoarticular
complications
18 (60%) 21 (70%) >0.05 a
aby v2test.
Table 2. Symptoms and signs of brucellosis in 30 patients
Characteristics Number (%) of patients
Symptoms
Fever 23 (76.7%)
Arthralgia ⁄ arthritis 19 (63.3%)
Headache 6 (20%)
Malaise 8 (26.7%)
Sweating 22 (73.3%)
Testicular pain 2 (6.7%)
Signs
Fever 23 (76.7%)
Arthritis 16 (53.3%)
Splenomegaly 18 (60 %)
Hepatomegaly 15 (50 %)
Orchitis 2 (6.7%)
Table 3. Laboratory results at diagnosis for 30 patients
with brucellosis
Number (%) of patients
WBC ⁄mm3
<4000 6 (20%)
4000–10000 24 (80%)
‡10000 0
Lymphocytes ‡40% 10 (33.3%)
Anaemia (male>12, female>10 g ⁄dL) 24 (80%)
ALT (>40 IU ⁄L) 9 (30%)
AST (>40 IU ⁄L) 8 (26.7%)
CRP (>1 mg ⁄L) 23 (76.7%)
ESR (>30mm ⁄h) 16 (53.3%)
Positive blood and bone marrow culture 16 (53.3%)
Positive (‡1 ⁄ 160) Wright’s test 30 (100%)
WBC, white blood cells; ALT, aspartate aminotransferase; AST, alanine amino-
transferase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.
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in the present study is located in eastern Turkey,
where most of the population consumes unpas-
teurised dairy products collected from villages, so
that the most common (63.3%) transmission route
was ingestion of milk products from diseased
animals. The disease usually presents with non-
speciﬁc clinical manifestations such as fever,
general malaise, profuse sweating, chills, hepato-
megaly or splenomegaly [1,2]. In the present
study, the symptoms were mainly fever (76.7%),
sweating (73.3%) and arthralgia ⁄ arthritis (63.3%),
while signs were mainly fever (76.7%) and
splenomegaly (60%), which are not sufﬁciently
speciﬁc to reach a diagnosis of brucellosis.
Liver and spleen enlargement with mild non-
speciﬁc elevation of liver enzyme levels can be
detected in approximately 50% of patients with
brucellosis [7]. ESR is of little diagnostic value
[13]. Common haematological ﬁndings include
leukopenia, anaemia and thrombocytopenia [14].
In most studies, the diagnostic value of routine
laboratory data has been low [4,15]. The rate of
isolation from blood is 10–70%, depending on the
methods used and period of incubation [1]. In the
present study, Brucella spp. were isolated from 16
patients. There was no signiﬁcant difference
between symptom duration in culture positive
and culture-negative cases.
The diagnosis of musculo-skeletal system
involvement in brucellosis is based on a patient’s
history, combined with physical examination and
imaging methods, of which radiography is the
method used most widely. The radiograph is
the initial means of evaluation of osteoarticular
involvement, although its lack of sensitivity in
the early stages must be considered [16,17]. In
the early and acute stages, diagnosis of osteoar-
ticular involvement can be difﬁcult because radi-
ography has a limited capacity when no changes
in bone are present. Moreover, relatively high
intra- and inter-observer variability is of concern
[18]. Other techniques that are still used widely
for imaging osteoarticular involvement are bone
scanning, computerised tomography and MRI
[19–21].
Bone scintigraphy has been shown to be a
sensitive method for detecting bone lesions of
brucellosis throughout the body. However, its
speciﬁcity is low [9–11], and this technique is not
useful in determining the outcome of brucellar
osteoarticular involvement because abnormal
uptake persists for a long period [22,23]. More-
over, bone scans do not detect soft tissue infec-
tion. This is a problem in diseases, such as
brucellosis, that have both osteoarticular and soft
tissue-related complications. In the present study,
bone scintigraphy did not detect paravertebral
abscess, although spondylitis and paravertebral
abscess were found in one patient.
The imaging of infection and inﬂammation
with radionuclides is becoming more complex,
largely because clinical situations for which such
studies are requested are changing and the
number of methods is increasing. HIG has been
introduced for imaging inﬂammation and, despite
early claims for several active mechanisms of
localisation, is now known to accumulate on the
basis of increased permeability. HIG localises at
inﬂammation, initially as a result of increased
endothelial permeability, followed by retention of
the label through binding to local extravascular
receptors [24]. When focal purulent disease is
suspected, the use of directly labelled HIG is not
recommended as the primary scintigraphic meth-
od [25]. HIG is the preferred method for detection
of non-pyogenic infections [24,25]. Tc-99m HIG
accumulation is a result of increased vascular
permeability, expansion of ﬂuid space available
for macromolecules, or binding to extracellular
matrix proteins such as ﬁbronectin, ﬁbrin, and
collagen types I and II [26,27]. Thus, Tc-99m HIG
uptake seems to reﬂect the presence and severity
of the inﬂammation directly, and has been shown
to be effective for detecting infection and inﬂam-
mation in different tissues [28–30].
Currently, a number of methods have been
described for imaging infection. Among these
methods, radiolabelling leukocytes is expensive
and time-consuming, and use of monoclonal Fab
fragment is more expensive than HIG. In the
present study, osteoarticular involvement of bru-
cellosis was detected at similar rates (p > 0.05) by
both bone and Tc-99m HIG scintigraphy.
Although osteoarticular involvement can be
detected by bone scan, this method has a low
speciﬁcity. HIG scintigraphy had a higher specif-
icity and was able to conﬁrm infection in the
osteoarticular compartment and detect soft tissue
infection in other body sites (orchitis, paraverte-
bral abscess, etc.). In this study, orchitis was
detected with HIG in two patients. Testicular US
was obtained for patients with orchitis.
Osteoarticular involvement is the most frequent
(25–76%) complication of brucellosis [4,8,15,31].
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The diversity of criteria used for the diagnosis of
osteoarticular involvement in brucellosis may
cause variations in results obtained by different
researchers. In the present study, the proportion
of patients with osteoarticular complications of
brucellosis was 60% by HIG and 70% by bone
scanning. Brucellosis may also affect the osteoar-
ticular system at any site [4,5]. In the present
study, the site affected most commonly was the
sacroiliac joint. Because sacroiliitis usually occurs
unilaterally in young people, it was possible to
differentiate it from non-infectious sacroiliitis
using HIG. Similarly, Cordera-Sanchez et al. [10]
and Tasova et al. [15] have reported a high rate of
bilateral sacroiliitis (60% and 47%, respectively).
As HIG scintigraphy can detect the inﬂammatory
process in bone and joints, degenerative skeletal
diseases have no deteriorating effect on the
diagnostic accuracy of HIG scintigraphy. In con-
trast, bone scintigraphy, a non-speciﬁc scinti-
graphic technique for detecting bone and joint
lesions, cannot differentiate between inﬂamma-
tory and degenerative skeletal pathologies.
In conclusion, HIG scintigraphy was non-inva-
sive, easy to perform, relatively inexpensive, and
might be a promising procedure for evaluating
osteoarticular and soft tissue-related complica-
tions of brucellosis.
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